Patent details

Basic Information

Publication number:

EP2100614

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP090751033

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Antibody against PDGFR-alpha for use in the treatment of tumours

French Title of Invention:

Anticorps contre PDGFR-alpha pour l'utilisation dans le traitement de tumeurs

German Title of Invention:

Antikörper gegen PDGFR-alpha zur Verwendung bei der Behandlung von Tumoren

SPC Number:

LUC00012

Dates

Filing date:

19/06/2006

Grant date:

09/10/2013

EP Publication Date:

09/10/2013

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

16/09/2009

EP B1 Publication Date:

09/10/2013

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

19/06/2026

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

17/10/2013

 

 

Name:

ImClone LLC

Address:

450 East 29th Street, 12th Floor, New York, NY 10016, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

23/10/2013

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

Loizos Nick

Address:

United States (US)

2

Name:

Huber Jim

Address:

United States (US)

Priority

Priority Number:

691920 P

Priority Date:

17/06/2005

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 38/17;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

23/05/2025

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

ANAQUA SERVICES (ANC. SGA2)

Filing date	Document type	Number of pages